Status:

RECRUITING

Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery

Lead Sponsor:

National Taiwan University Hospital

Collaborating Sponsors:

Alcon Research

Conditions:

Ophthalmology

Eligibility:

All Genders

20-85 years

Phase:

PHASE4

Brief Summary

Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.

Detailed Description

STUDY OBJECTIVE:To evaluate the impact of predicted residual astigmatism in mixed dry eye patients regularly using Systane COMPLETE before cataract surgery. Hypothesis:Regular use of Systane COMPLETE...

Eligibility Criteria

Inclusion Criteria:

The subjects aged 20-85 years, with normal cognitive function and capable of answering related questionnaires who require phacoemulsification and intraocular lens implantation under topical anaesthesia, are the eligible candidates.

Exclusion Criteria:

  1. Unable to answer the questions in the dry eye survey.
  2. Ocular trauma or ocular surgery in the planned surgical eye, active ocular infection, and obvious abnormalities in ocular surface or eyelid margins other than MGD cause decreased visual acuity other than cataracts.
  3. Dry eye signs: Corneal Fluorescein Staining CFS (+) to exclude any corneal abnormalities or epithelial defect
  4. Systemic drug use, including tetracycline derivatives, antihistamines, and isotretinoin.
  5. Using dry eye medication at screening stage

Key Trial Info

Start Date :

May 2 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT06763731

Start Date

May 2 2024

End Date

December 31 2026

Last Update

November 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan, Taiwan